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Background and Objective: Mitral valve repair is the procedure of choice to 
correct mitral regurgitation of all types. Up to 10% of patients who undergo 
mitral valvuloplasty require late reoperation for recurrent mitral valve dys- 
function. To determine the causes of failed mitral valve repair, we examined 
the surgical pathology of patients who underwent reoperation for failed mitral 
valve repair. Patients and Results: From 1986 to 1994, 81 patients had 86 
reoperations for recurrent mitral egurgitation after mitral valve repair. Mean 
age was 59.2 +- 1.4 years; 55 were men. Primary valve disease was degenerative 
in 48 patients (59%), rheumatic in 16 (20%), ischemic in 13 (16%), endocarditic 
in 3 (4%), and congenital in 1 (1%). Mean time interval between initial mitral 
valve repair and reoperation was 15.6 - 2.5 months. Causes of repair failure 
were procedure-related (50 cases, 58%), valve-related (33 cases, 38%), or 
unknown (3 cases, 3%). Procedure-related valve failure was caused by suture 
dehiscence (21 cases), rupture of previously shortened chordae (19 cases), or 
incomplete initial correction (10 cases). Valve-related repair failure was caused 
by progressive primary valve disease (27 cases), endocarditis (5 cases), or 
extensive leaflet retraction (1 case). Repair failure was procedure-related in 
70% of patients with degenerative alvular disease versus only 13% of patients 
with rheumatic valvular disease (p = 0.0001). At reoperation, mitral 
valve replacement was performed in 64 patients (79%) and repeat mitral valve 
repair in 17 (21%). Conclusion: We conclude that (1) most mitrai valve repair 
failures are procedure-related in degenerative disease nd valve-related in
rheumatic disease; (2) rupture of previously shortened chordae is a common 
cause of late failure in patients with degenerative mitral valve disease; and (3) 
repeat mitral valve repair results in successful treatment for a minority of 
patients. (J Thorac Cardiovasc Surg 1997;113:467-75) 
M itral valve is the procedure of choice for repair 
mitral regurgitation (MR) of all etiologies. 1-7 
Numerous studies have documented that mitral 
From the Departments of Thoracic and Cardiovascular Surgery ~
and Biostatistics and Epidemiology, b The Cleveland Clinic 
Foundation, Cleveland, Ohio. 
Read at the Seventy-sixth Annual Meeting of The American 
Association for Thoracic Surgery, San Diego, Calif., April 
28-May 1, 1996. 
Received for publication May6, 1996; revisions requested June 
19, 1996; revisions received Oct. 7, 1996; accepted for publi- 
cation Nov. 19, 1996. 
Address for reprints: Delos M. Cosgrove, MD, Department of
Thoracic and Cardiovascular Surgery, The Cleveland linic 
Foundation, 9500 Euclid Ave., Cleveland, OH 44195. 
Copyright © 1997 by Mosby-Year Book, Inc. 
0022-5223/97 $5.00 + 0 12/6/79335 
valve repair performed by standardized techniques 
is reproducible and associated with low operative 
morbidity and mortality. 1-7 Advantages of mitral 
valve repair over mitral valve replacement (MVR) 
include lower operative mortality, better preserva- 
tion of left ventricular function, and higher freedom 
from thromboembolism, anticoagulant-related hem- 
orrhage, and endocarditis. 4' s-12 Given these advan- 
tages, an increasing proportion of surgeons is using 
mitral valvuloplasty to treat mitral insufficiency. 
Although the feasibility of mitral valve repair 
extends to 95% of patients with degenerative valvu- 
lar disease and up to 75% of patients with rheumatic 
or ischemic valvular disease, nearly all reports de- 
scribe patients who have required reoperation for 
recurrent mitral valve dysfunction. 1-7 The longest 
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Table I. Repair techniques used at initial operation 
Repair technique No. % 
Annuloplasty 78 91 
Carpentier 39 45 
Pericardial 25 29 
Cosgrove 5 6 
Duran 5 6 
Other 4 5 
Resection of posterior leaflet 27 31 
Resection of anterior leaflet 4 5 
Chordal shortening 25 29 
Chordal transfer 12 14 
D6bridement 9 10 
Commissurotomy 8 9 
Leaflet patching 4 5 
Suture repair of cleft leaflet 2 2 
fol low-up to date is reported by Deloche and asso- 
ciates, 1with a 15-year actuarial  f reedom from reop- 
erat ion of 87.4% after mitral  valvuloplasty. Thus 
reoperat ion to t reat  recurrent  MR is a significant 
late morbidity associated with mitral  valve repair. 
A l though the incidence of repair  fai lure and risk 
factors for recurrent  valve dysfunction are well 
documented,  little data exist concerning the mech- 
anisms of recurrent  mitral  valve dysfunction after 
mitral  valve repair  or success of subsequent treat- 
ment modalit ies. Such information could aid in the 
selection of pat ients and techniques for mitral  val- 
vuloplasty. This study was undertaken to determine 
the causes of fai led mitral  valve repair.  
Patients and methods 
Between January 1986 and December 1994, 81 patients 
had 86 operations at The Cleveland Clinic for recurrent 
mitral valve dysfunction after initial mitral valve repair for 
MR. Patients having unsuccessful mitral valve repair 
followed by MVR at the same operative procedure were 
not included in this analysis. Nineteen of the 81 patients 
had initial mitral valvuloplasty at another institution and 
were referred to The Cleveland Clinic for treatment of 
recurrent valve dysfunction. Mean age at the time of 
reoperation was 59.2 -+ 1.4 years (range 18 to 79 years); 55 
patients were men. The primary valve disease was degen- 
erative in 48 patients (59%), rheumatic in 16 (20%), 
ischemic in 13 (16%), endocarditis n 3 (4%), and con- 
genital in 1 (1%). 
MR was the indication for initial valve repair in all 81 
patients. Severity of MR was determined before the 
operation by echocardiogram Or cardiac catheterization, 
or both. 13 Before mitral valvuloplasty, all patients had 
grade 3+ or 4+ MR on a scale of 0 to 4+; mean degree 
of MR was 3.5 + 0.1. Mean New York Heart Association 
(NYHA) functional class was 2.7 -+ 0.1, with 57 patients 
(70%) in class III or IV. Left ventricular function was 
normal or mildly impaired in 62 patients. 
At the time of reoperation, all patients had recurrent 
Table II. Causes of failed mitral valve repair 
Cause of failed repair No. * % 
Procedure-related 50 58 
Suture dehiscence 
Annuloplas~ 15 17 
Leaflet repair 6 7 
Ruptured chordae (previously shortened) 19 22 
Incomplete repair 10 12 
Valve-related 33 38 
Progressive disease 27 31 
Endocarditis 5 6 
Leaflet retraction 1 1 
Unknown 3 3 
*Results were tabulated for 86 procedures in 81 patients. 
MR that was grade 3+ or 4+ (mean MR grade 3.4 -+ 0.1). 
All 81 patients underwent reoperation for failed mitral 
repair at The Cleveland Clinic. Five patients underwent a 
third operation at The Cleveland Clinic after a second 
mitral valvuloplasty failed; thus there were 86 operations 
for failed mitral valve repair. All patients had echocardio- 
grams before reoperation. The predominant cause of 
recurrent mitral valve dysfunction was determined by 
echocardiogram and the surgeon's findings at operation. 
Techniques used at initial mitral valve repair are sum- 
marized in Table I. Seventy-eight of 86 operations in- 
cluded annuloplasty. Most annuloplasties were performed 
with either a Carpentier-Edwards ring (Baxter Healthcare 
Corp., Edwards Div., Santa Ana, Calif.) or a strip of 
glutaraldehyde-treated bovine pericardium. TM An average 
of 1.9 repair techniques were used in each patient. Forty- 
two patients had additional cardiac procedures: coronary 
artery bypass grafting in 24 patients, aortic valve repair or 
replacement in 13, and tricuspid valvuloplasty in 7. Intra- 
operative echocardiography was used to assess mitral 
valve repair in 56 patients (transesophageal chocardiog- 
raphy in 41; epicardial echocardiography in 13; trans- 
esophageal nd epicardial echocardiography in 2). After 
mitral valvuloplasty, mean grade of MR by intraoperative 
echocardiography was 0.6 -+ 0.1 (p < 0.0001 vs preoper- 
ative degree of MR). 
Follow-up data were available for 72 of 74 hospital 
survivors (97%). Follow-up information was obtained 
during outpatient clinic appointments or by telephone 
interview with the patient or referring cardiologist, or 
both. Mean duration of follow-up was 45.9 +- 3.3 months 
(range 1 to 115 months). Late echocardiograms were 
obtained on all patients who underwent re-repair of the 
mitral valve. 
Statistical analyses. Unless otherwise indicated, all val- 
ues are expressed as mean _+ standard error of the mean. 
Primary valvular disease and mode of failure were ana- 
lyzed for their relationship to time to repair failure. When 
normality or variance homogeneity was questionable, 
results of nonparametric tests were compared with the 
analysis of variance. Nonparametric results were used 
when significant discrepancies occurred. For time to event 
analyses, Kaplan-Meier curves were generated. Fisher's 
exact test was generated to test for effect of primary 
valvular disease on cause of repair failure; to preserve 
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Table III. Causes of failed mitral valve repair and primary valve disease 
Primary valve disease* (%) 
Degen Rheum Isch Endo Cong 
Cause of repair failure (N = 48) (N - 16) (N = 13) (?4 = 3) (N = 1) 
Procedure-related 
Ruptured chordae (previously shortened) 36 0 8 0 0 
Suture dehiscence 22 13 23 100 100 
Incomplete surgery 12 0 23 0 0 
Valve-related 
Progressive disease 22 74 31 0 0 
Endocarditis 2 13 8 0 0 
Leaflet retraction 2 0 0 0 0 
Unknown 2 0 8 0 0 
Degen, Degenerative; Rheum, rheumatic; Isch, ischemic; Endo, endocarditis; Cong, congenital. 
*Results were tabulated for 8l patients; in patients having two operations for failed mitraI valve repair only the initial procedure was tabulated. 
independence b tween observations, only the first repair 
failure was analyzed in patients having two failed mitral 
repairs. A significance l vel of 0.05 was used for all testing. 
Results 
Mean time interval between initial mitral valve 
repair and reoperation was 15.6 ± 2.5 months 
(range 3 hours to 100 months). Ten patients under- 
went reoperation during the same hospitalization as
the initial mitral valvuloplasty; in 7 of these, the 
operation was performed on an emergency basis for 
acute hemodynamic compromise. 
Causes of failed mitral valve repair are depicted 
in Table II. Recurrent valve dysfunction was caused 
by either procedure- or valve-related factors. Over- 
all, 50 of 86 failures were procedure-related, 33 were 
valve-related, and 3 were of unknown cause. Proce- 
dure-related causes of valve dysfunction included 
rupture of previously shortened chordae (19 cases), 
suture dehiscence of an annuloplasty ring (15 cases) 
or leaflet repair site (6 cases), and incomplete initial 
repair (10 cases). Incomplete initial repair was 
judged to be the cause of repair failure when MR 
was 2+ or greater by postrepair echocardiogram in 
the operating room or in the early postoperative 
period. Two patients with incomplete initial repair 
had systolic anterior motion of the mitral valve and 
left ventricular outflow tract obstruction as the cause 
of their MR. Valve-related causes of recurrent MR 
included progressive native valve disease (27 cases), 
endocarditis (5 cases), and excessive leaflet retrac- 
tion (1 case). 
Table III shows the relationship between mecha- 
nism of repair failure and primary valve disease. In 
patients with degenerative disease, 70% of valve 
failures were caused by procedure-related factors. 
Table IV. Operative morbidity at reoperation 
Event No. % 
Reoperation for bleeding 7 8.1 
Respiratory failure 5 5.8 
Stroke 4 4.6 
Sternal infection 3 3.5 
Intraaortic balloon pump 3 3.5 
Myocardial infarction 2 2.3 
Gastrointestinal hemorrhage 2 2.3 
Renal failure 1 1.2 
Pulmonary embolism 1 1.2 
Rupture of previously shortened chordae was the 
most common cause of recurrent MR in patients 
with degenerative valvular disease. In contrast, 
valve-related factors were responsible for recurrent 
MR in 87% of patients with rheumatic disease (p = 
0.0001 vs patients with degenerative disease); pro- 
gressive native valve disease was the predominant 
cause of repair failure in patients with rheumatic 
valvular disease, and this was characterized by leaf- 
let fibrosis and retraction. In patients with ischemic 
MR, recurrent MR developed for a variety of rea- 
sons; procedure-related failure occurred in 54% of 
patients and valve-related failure in 39%. One pa- 
tient who had mitral valvuloplasty for endocarditis 
had recurrent endocarditis n the repaired valve. 
Timing of reoperation was dependent on the 
mechanism of repair failure. Mean time interval 
between initial mitral valvuloplasty and reoperation 
was 22.5 ± 4.5 months for patients with valve- 
related failure versus 12.8 ± 3.2 months for patients 
with procedure-related failure (p = 0.002). In addi- 
tion, there was a trend toward longer time to 
reoperation i  patients with rheumatic valvular dis- 
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Fig. 1. Kaplan-Meier curve of freedom from reoperation 
after repeat mitral valve repair (n ~ 17). 
ease than in patients with degenerative valvular 
disease (median time intervals of 14 months and 6.5 
months, respectively); however, this difference was 
not statistically significant (p = 0.08). 
Reoperations included MVR in 64 patients (79%) 
and repeat mitral valve repair in 17 patients (21%). 
Associated procedures were performed in 18 pa- 
tients and included coronary artery bypass grafting 
(n = 7), aortic valve repair or replacement (n = 4), 
tricuspid valve repair or replacement (n = 6), and 
closure of patent foramen ovale (n = 2). There were 
7 operative deaths, for an operative mortality of 
8.6%. All operative deaths occurred in patients 
undergoing MVR. Causes of operative mortality 
included sepsis (3 patients), left ventricular failure 
(2 patients), and stroke (2 patients). Significant 
operative morbidity is summarized in Table IV. 
The 17 patients treated by repeat mitral valve 
repair included 10 patients with degenerative alvu- 
lar disease, 3 patients with rheumatic valvular dis- 
ease, 2 patients with ischemic valvular disease, 1 
patient with endocarditis, and 1 patient with con- 
genital mitral insufficiency. Six of these 17 patients 
subsequently required MVR (Table V). After 
repeat valve repair, 5-year freedom from reopera- 
tion on the mitral valve was 60.5% _+ 13.3% (Fig. 
1). Of 10 patients with degenerative mitral disease 
undergoing a second mitral valve repair, only 1 re- 
quired subsequent MVR. At mean follow-up of 56.8 _+ 
6.1 months, 11 patients with successful repeat mitral 
valve repair are in NYHA functional class I and none 
has had any valve-related morbidity; mean degree of 
MR in these patients is 0.5 _+ 0.2. 
There have been 14 late deaths at a mean fol- 
low-up of 45.9 -2_ 3.3 months (range 1 to 115 
Table V. Causes of failed mitral re-repair 
Cause of first Cause of second 
Patient Valve disease failure failure 





Rheumatic Progressive disease Inadequate surgery 
Rheumatic Progressive disease Progressive disease 
Ischemic Endocarditis Chordal rupture* 
Ischemic Dehiscence Unknown 
(annuloplasty) 
6 Endocarditis Dehiscence Endocarditis 
(annuloplasty) 
*Chordae were previously shortened. 
months) (Table VI). Five-year survival was 84.6% +_ 
4.6% (Fig. 2). Of 60 long-term survivors, 59 are in 
NYHA functional class I or II. Four patients who 
underwent MVR required repeat MVR, 2 for pros- 
thetic valve endocarditis and 2 for structural deteri- 
oration of a bioprosthetic valve. 
Discussion 
Since the introduction of standardized techniques 
for mitral valve reconstruction by Deloche,1 Carpen- 
tier, 2 Duran, 7 and others, 3-6 mitral valve repair has 
become the surgical treatment of choice for MR. 
Numerous retrospective studies have demonstrated 
significant benefits of mitral valve repair over MVR 
in patients with mitral insufficiency. 8-~2 Deloche and 
associates I have stated that mitral reconstruction is 
feasible in 95% of patients with degenerative alvu- 
lar disease, 70% with rheumatic valvular disease, 
and 75% with ischemic valvular disease. Others have 
confirmed this experience. 5' 7 
Although mitral valve reconstruction has several 
significant advantages over MVR, the incidence of 
late reoperation is equal after the two proce- 
dures.4, s-10 Mitral valve reconstruction is followed 
by a high initial instantaneous risk of valve failure 
and a subsequent low constant risk of late valve 
failure.5, 11, 12 Most authors report a 5-year freedom 
from reoperation of approximately 90%.  4-(~' 15-17 De- 
loche and coworkers 1 report a 15-year actuarial 
freedom from reoperation of 87% after repair of 
insufficient mitral valves. 
Several factors increase the risk of late reopera- 
tion after mitral valve repair. These include rheu- 
matic disease, advanced myxomatous changes of 
both leaflets, chordal shortening procedures, failure 
to perform an annuloplasty, residual MR at the 
completion of repair, NYHA functional class III or 
IV, and performance of concomitant cardiac proce- 
dures.i. 16-2~ Most of these risk factors are related 
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Table VI. Causes of late death 
Cause of late death No. of patients 
Congestive heart failure 3 
Myocardial infarction 2 
Operative mortality (redo MVR) 2 
Pneumonia 2 
Pulmonary embolism 1 
Lung cancer 1 
Unknown 3 
either to the surgical procedure or to the patient's 
native valve disease. 
Rheumatic disease is the most well-established 
risk factor for late failure after mitral valvuloplas- 
ty.l, 7, 11,21-25 Deloche and associates t found that 
15-year actuarial freedom from reoperation after 
repair was 76% in patients with rheumatic mitral 
disease versus 93% in those with degenerative mitral 
disease. Duran, 2224 Galloway, 6 and others z5 have 
confirmed this observation. Duran and col- 
leagues 22-24 have emphasized that younger patient 
age and active rheumatic arditis are additional risk 
factors for reoperation. 
Although series from Europe contain large pro- 
portions of patients with rheumatic disease, degen- 
erative valvular disease is the most common cause of 
MR in North America. 3' 15-17 Cohn and associates iv 
found that failure to perform a ring annuloplasty 
increased the risk of recurrent MR in patients with 
degenerative., mitral disease. Recent data demon- 
strate that chordal shortening is an additional risk 
factor for recurrent operation in patients with de- 
generative mitral disease. 18 For patients with ante- 
rior leaflet prolapse, Smedira and coworkers i re- 
ported 5-year freedom from reoperation of 74% in 
patients having chordal shortening versus 96% in 
patients undergoing chordal transfer. Recurrent 
MR in patients having chordal shortening was 
caused by chordal rupture at the site of insertion 
into the papillary muscle. Others have also observed 
this complication associated with chordal shortening 
procedures. 26
Although risk factors for reoperation after mitral 
repair have been identified, few studies have system- 
atically examined the precise mechanism of recur- 
rent valve dysfunction. In a review of 72 patients 
undergoing late reoperation after mitral valve re- 
pair, E1 Asmar and coworkers 27 proposed that fail- 
ure could be classified as surgeon-related or valve- 
related. In this experience, most repair failures were 
surgeon-related in degenerative disease and valve- 
related in rheumatic disease. Devising a similar 
100 
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Fig. 2. Kaplan-Meier curve of late survival after eopera- 
tion for failed mitral valve repair (n = 72). 
classification system, Duran 7 proposed four possible 
causes of failure necessitating reoperation after 
mitral valve repair: wrong indication, technical er- 
ror, instability of the repair technique, and progres- 
sion of the disease process. 
The purpose of this study was to identify the 
mechanisms of failed mitral valve repair. As noted 
previously, other authors have determined the inci- 
dence of recurrent mitral valve dysfunction and have 
identified risk factors for repair failure. This study of 
86 reoperations for failed mitral repair is the largest 
reported series. Analysis revealed that the mecha- 
nism of valve failure could be classified as either 
procedure-related or valve-related, similar to the 
observations of E1 Asmar's group 2v and Duran. 7 
Unlike reports of these two authors, the majority of 
patients in this series had degenerative mitral valve 
disease. Procedure-related factors were the most 
common cause of recurrent valve dysfunction neces- 
sitating reoperation, confirming the findings of E1 
Asmar and colleagues. 27 Rupture of previously 
shortened chordae was the single most common 
cause of valve failure in this group. Because of this 
observation, chordal transposition is favored over 
chordal shortening for correction of anterior leaflet 
prolapse. 
Other important causes of valve failure in patients 
with degenerative disease included suture dehis- 
cence, progressive native valve disease, and incom- 
plete initial operation. Suture dehiscence occurred 
at sites of leaflet resection and at the annuloplasty 
ring. Dehiscence of the annuloplasty was unpredict- 
able and occurred with all techniques. Progression 
of degenerative valve disease usually presented as 
elongation or rupture of previously untreated chor- 
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dae. Six patients with degenerative alvular disease 
had incomplete initial correction of MR. Three of 
these cases occurred before the routine use of 
intraoperative echocardiography. In the remaining 3
cases, intraoperative echocardiogram revealed re- 
sidual MR that was 2+ or greater after repair. A 
previous tudy demonstrated that this is a risk factor 
for late reoperation. 19
As in large series reported by Duran, 22-24 De- 
loche, 1 Carpentier, 2 and others, 25' 27 repair failure 
was attributable to valve-related factors in the ma- 
jority of patients with rheumatic valves. Progressive 
rheumatic hanges were the most common cause of 
reoperation in patients with rheumatic mitral dis- 
ease. None of the patients had active rheumatic 
carditis at initial operation. At reoperation, most of 
these patients had progressive valve sclerosis with 
leaflet retraction. Others have noted similar post- 
rheumatic hanges in the absence of active rheu- 
matic carditis. 23-25 Duran 22-24 and others 25 demon- 
strated that mitral valve repair is less durable in 
those with rheumatic disease. Patients with rheu- 
matic disease undergoing mitral valvuloplasty here- 
fore require careful postoperative follow-up. 
Ischemic mitral insufficiency has traditionally 
been a surgical challenge. Until recently, confusing 
classification schemes and an incomplete under- 
standing of pathophysiology have made repair of 
such valves difficult. 2s Kay and associates 29 have 
documented the largest experience with mitral val- 
vuloplasty for ischemic MR, and they report 94% 
freedom from reoperation at 10 years. In the current 
series, 13 patients with ischemic MR required reop- 
eration after failed repair. Causes of failed repair 
were varied, with procedure- and valve-related fac- 
tors accounting for nearly equal numbers of reop- 
erations. Lack of a predominant cause of recurrent 
MR in this group may reflect the wide variety of 
pathophysiologic mechanisms responsible for isch- 
emic MR. 
Operative mortality for patients undergoing reop- 
eration after failed mitral reconstruction was 8.6%, 
which agrees with the 8.8% operative mortality 
reported by Niederhauser and colleagues. 3°Seven- 
ty-nine percent of patients underwent MVR, and 
21% had re-repair of their native mitral valves. 
Surgical treatment of recurrent MR after mitral 
valvuloplasty is controversial. E1 Asmar and associ- 
ates 27 performed a second mitral valve repair in 
15.3% of patients with failed mitral valvuloplasty. 
Others suggest that failed mitral valve repair should 
always be treated by MVR. 3° Of 17 patients having 
a second mitral valvuloplasty, 6 required a third 
operation for recurrent mitral dysfunction. Of note, 
in only 1 of 10 patients with degenerative disease 
was a second mitral valve repair unsuccessful. These 
results uggest that select patients with degenerative 
disease can undergo successful repeat mitral valve 
repair when initial mitral valvuloplasty fails. 
Mitral valve repair is the procedure of choice for 
most patients with mitral insufficiency. Although 
morbidity is low, previous studies demonstrate hat 
after 5 years approximately 10% of patients will 
require reoperation for recurrent mitral valve dys- 
function. As surgeons take a more aggressive ap- 
proach toward repair and the number of mitral 
repair procedures increases, the incidence of unsuc- 
cessful mitral repair might be expected to increase. 
However, greater operator experience, chocardio- 
graphic monitoring, elimination of unsuccessful 
techniques, and decreasing prevalence of rheumatic 
disease should minimize the incidence of repair 
failure. 
This study identifies mechanisms of failed mitral 
valve repair. In a group of patients with predomi- 
nantly degenerative mitral valve disease, procedure- 
related factors were responsible for most cases of 
recurrent MR. This suggests that careful patient 
selection and precise application of surgical tech- 
niques can reduce the rate of late repair failure. By 
eliminating incomplete repair and abandoning the 
technique of chordal shortening, 34% of repair 
failures could be avoided. Routine use of intraoper- 
ative echocardiography to assess mitral repair 
should virtually eliminate incomplete correction as a 
cause for late reoperation. When reoperation is 
necessary after failed mitral repair, a small percent- 
age of patients with degenerative disease can be 
treated successfully by repeat mitral valve repair. 
We thank Christopher Barr, BS, for assistance in ana- 
lyzing the data and application of statistical methods. 
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Discussion 
Dr. Tirone E. David (Toronto, Ontario, Canada). The 
authors concluded that the principal cause of failure of 
mitral valve repair was related to the operation in patients 
who had MR as a result of degenerative disease; in those 
patients who had ischemic MR, the cause of failure was 
due to the progression of the valve disease. They point out 
that the rupture of previously shortened chordae tendi- 
neae was the principal cause of failure in patients with 
degenerative disease. We agree with their conclusions, 
and Our experience is similar. What Dr. Gillinov did not 
mention is the frequency of these problems. 
I have a few questions for Dr. Gillinov. First, how often 
does the mitral valve repair fail in each subgroup? How 
often do shortened chordae tendineae rupture in patients 
with floppy mitral valves? Finally, should chordal short- 
ening be abandoned altogether if it is the cause of the 
failures in one third of the cases? 
We reviewed our experience with 512 patients who had 
mitral valve repair from 1979 to 1993. In 309 the repair 
was done for degenerative disease of the mitral valve, and 
during a mean follow-up of 42 months, the failure rate was 
3%. The actuarial freedom from failure was 96% at 10 
years. All these failures occurred in the first year, indicat- 
ing again that Dr. Gillinov is correct in stating that failure 
after repair of myxomatous mitral valve is largely related 
to technical problems. A regression analysis in this study 
showed that bileaflet prolapse and advanced myxomatous 
change in both leaflets were the two independent predic- 
tors of failure. In patients with ischemic MR, all failures in 
our experience were procedure-related. The failures oc- 
curred very early, in the first 7 months after the operation, 
indicating the complexities in repairing ischemic MR. 
Finally, like the authors' experience in rheumatic mitral 
valve repair, most of our failures were due to a progres- 
sion of the disease, but they happened much later, after a 
mean time of 6 to 7 years, as opposed to the 25 months 
observed by Dr. Gillinov. 
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Dr. Alain F. Carpentier (Paris, France). I basically agree 
with the conclusions expressed in this paper, with some 
differences that I would like to underline. The 3.1% 
incidence of reoperation in your paper relates to the 
global number of valve operations. We would like to know 
what the incidence is in relation to the number of mitral 
valve repairs. The incidence in our experience accounted for 
3.9% in a series of 3000 consecutive mitral valve repairs. 
With regard to the annuloplasty, ou have been using 
two basic types of approaches, and I notice that failure 
represented the third most frequent cause of reoperation; 
in our series, using exclusively remodeling annuloplasties, 
ring dehiscence was the least frequent cause of reopera- 
tion, with an incidence of 0.6%. Is this due to a higher 
incidence of failure in the group having pericardial rein- 
forcement? If not, how do you explain this difference? 
With regard to chordal rupture after chordal shorten- 
ing, I do agree that this is one of the main causes for 
reoperation, actually the second cause for us after pro- 
gressive valve disease. However, again, we should corre- 
late the number of reoperations for this cause to the 
number of chordal shortenings performed. In our series 
chordal rupture accounted for only 4% of the chordal 
shortenings performed. Thus, before advising that this 
technique be abandoned, we must be sure that the alter- 
native techniques can challenge this result over the long 
term. I cannot present a new approach, a new technique 
we have developed to minimize the drawbacks associated 
with the chordal shortening, because it is too difficult to 
explain without a slide. 
Another new approach we have been exploring is valve 
repairs through a minithoracotomy with video assistance 
and peripheral extracorporeal circulation. Including the 
first operation, which took place last February, four patients 
have been operated on successfully. We were struck by the 
rapid recovery of these patients, but also by the greater 
difficulty of the operation; therefore we should be extremely 
cautious in the development of this approach. 
Dr. Lawrence H. Cohn (Boston, Mass.). This manuscript 
is full of important details for those who do a lot of mitral 
valve repairs: I think the issue here is primarily how to 
handle the anterior leaflet of the mitral valve for the 
floppy mitral valve that has very elongated chordae. 
We have also observed ruptured chordae in the papil- 
lary muscle trench. I think this complication is due to 
the fact that when the surgeon ties down the suture on the 
trench, he or she may actually tie the suture onto the 
chordal structure itself, leading to late rupture in these 
particularly fragile Chordae. Therefore our current tech- 
nique is to use polytetrafluoroethylene (PTFE) chordae, 
namely, the CV-5 Gore-Tex PTFE chordae.* We find that 
technique has several advantages. It is easy to use, and we 
think that the other chordae should also be left intact 
should anything happen. I am told that the symposium 
conducted at this meeting showed that there has been 
relatively minimal morbidity with the use of this technique 
now for 10 years. We believe that the PTFE chordae 
might be a little bit simpler and extremely reliable rather 
than the chordal transfer. What is the favorite technique 
*Gore-Tex prosthetic tissue, registered trademark ofW. L. Gore 
& Associates, Inc., Elkton, Md. 
for chordal elongation shortening at the Cleveland Clinic 
at the present ime? 
Dr. Carlos G. Duran (Missoula, Mont.). This is an 
important paper because now that everybody agrees that 
rePair is the preferred modality for the surgical treatment 
of mitral disease, it is good to hear about problems. 
After listening to the paper, I still do not know what the 
incidence of failures was according to etiology and pathol- 
ogy. Apparently 59% of the cases were degenerative, but 
how many of these repairs failed and how many of the 
repairs for rheumatic disease? I am also surprised at the 
large number of ring dehiscences reported. Did you use 
different echniques and rings? In our experience this is a 
rare complication. My third question is whether you have 
tried to correlate these reoperations with the quality of 
repair immediately after the initial operation as evaluated 
by transesophageal echocardiography. Not all patients 
leave the operating room with the same degree of success. 
I agree with the previous comments about he increased 
use of PTFE. I think it might prove to be the solution for 
anterior mitral prolapse. Finally, I have a comment hat 
probably does not apply to this country but that we have 
found germane in the very young patient in the developing 
world: There is a very rapid rate of change in the 
echocardiographic left ventricular dimensions after sur- 
gery. After a few days these dimensions are reduced by 
nearly 30%, and consequently the shortened chordae to 
the anterior leaflet become too long, resulting in MR. 
Dr. Gillinov. We would like to thank the discussants for 
all of their thoughtful comments. In response to Dr. 
David's questions, he and the other discussants asked 
what the incidence of repair failure is for each type of 
valve pathology at the Cleveland Clinic. We are currently 
conducting a long-term follow-up study to answer this 
question, so I do not yet have that data for you. Dr. David 
noted that the freedom from reoperation after repair for 
degenerative mitral valve disease among his patients is 
96% at 10 years, which certainly is excellent and compares 
favorably with other reports. With the longest follow-up to 
date, Dr. Carpentier's group has reported a 13% inci- 
dence of reoperation after mitral repair at 15 years' 
follow-up; the incidence of reoperation is higher for those 
with rheumatic mitral disease. 
Dr. David also asked about the frequency of chordal 
rupture after chordal shortening. In a study published in 
The Journal of Thoracic and Cardiovascular Surgery (1996; 
112:287-92), we report a 74% 5-year freedom from reop- 
eration after chordal shortening for anterior leaflet pro- 
lapse in degenerative mitral disease. In contrast, we found 
a 96% 5-year freedom from reoperation after repair of 
anterior leaflet prolapse using chordal transfer tech- 
niques, and this difference was statistically significant. 
Finally, Dr. David asked if we would therefore recom- 
mend abandoning the chordal shortening technique. Like 
Dr. Carpentier, we do not recommend abandoning any 
particular technique until we have something that we can 
demonstrate is clearly superior. At 5 years we show that 
chordal transfer is superior to chordal shortening, and 
there is now emerging data that replacement of chordae 
with synthetic materials, like PTFE, may also be better. 
Dr. Carpentier also asked what our incidence of repair 
failure was by pathology. We will have that information 
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soon. Similarly, I do not yet have the data for the 
incidence of annuloplasty dehiscence according to annu- 
loplasty technique. Certainly annuloplasty dehiscence was 
an important cause of failure, causing 17% of repair 
failures in our series. Dr. Carpentier agreed that failure is 
more common after chordal shortening than after other 
techniques of repair for anterior leaflet prolapse. Again, I 
agree that we must test other methods before recom- 
mending the abandonment of this technique. We cur- 
rently have no experience with minimally invasive ap- 
proaches to mitral valve repair but certainly look forward 
to future presentations on this topic. 
Dr. Cohn commented on treatment of anterior leaflet 
prolapse, agreeing with the other discussants. The precise 
cause of rupture of previously shortened chordae is riot 
completely understood. It certainly has something to do 
with the fact that these are structurally abnormal, weak- 
ened chordae and is probably also related to difficulty in 
judging the appropriate l ngth of these chordae. At The 
Cleveland Clinic we favor chordal transfer over chordal 
shortening for correction of anterior leaflet prolapse. 
Finally, Dr. Duran asked about our incidence of ring 
dehiscence, as it is an infrequent cause of late failure in 
his series. Approximately 50% of the patients in this 
series had a remodeling annuloplasty using a Carpentier- 
Edwards ring, and the second most common technique 
was posterior annular plication with a pericardial strip. 
The latter technique we have since abandoned because it 
is difficult to achieve a measured plication of the anulus. 
This technical difficulty may have contributed to repair 
failure in some patients. Dr. Duran asked us to relate the 
incidence of reoperation to the degree of MR at the 
completion of repair. We do have data to demonstrate 
that at the completion of repair, if MR is 1 + or 2+, the 
incidence of late reoperation is increased threefold over 
those who have trace or no MR at the en d of repair. Thus 
incomplete initial repair is an important cause of repair 
failure. 
